HOME >> MEDICINE >> NEWS
AMPAKINE compounds a new potential treatment for respiratory depression

Drug-induced respiratory depression is a life-threatening condition caused by analgesic, hypnotic, and anesthesia medications. Although it is a leading cause of death from the overdose of some classes of abused drugs, respiratory depression also arises during normal, physician-supervised procedures such as surgical anesthesia, post-operative analgesia, and as a result of normal out-patient management of pain from cancer, accidents, or illnesses.

The majority of adverse events occurring with these drugs take place during the dose adjustment period, when two or more central nervous depressants are taken together, or when patients take prescribed drugs in ways not intended by their physician.

Although only 0.5%-1.2% of total adverse drug events caused by prescription medications are respiratory in nature, these serious side effects account for 25%-30% of drug-induced deaths. Opiates and barbiturates are the primary drugs classes responsible for these effects. Opiates include the standard pain-killing drugs morphine, fentanyl, and codeine, as well as related products vicodin, hydrocodone, and oxycontin. Barbituates comprise the sedative drugs amobarbital, aprobarbital, butabarbital, pentobarbital, and others. Sleeping disorders are another common predisposing factor for respiratory depression, in this case known as sleep apnea.

Currently, the only way to counter opiate-induced respiratory depression is to administer opiate receptor antagonists, drugs that block the effectiveness of opiate analgesia. While this approach may prevent a serious side effect or even death, it dramatically reduces the effectiveness of drugs administered for management of severe pain.

Researchers at the University of Alberta (Edmonton, AB) and Cortex Pharmaceuticals (Irvine, CA) believe that AMPAKINE drugs may provide protection from drug-induced respiratory depression, while simultaneously allowing the sedative or analgesic to continue working as it
'"/>

Contact: Mark Varney
mvarney@cortexpharm.com
949-231-0672
Cortex Pharmaceuticals
4-Jun-2007


Page: 1 2 3 4 5

Related medicine news :

1. New oxidation methods streamline synthesis of important compounds
2. Depression among retired NFL players: Rates mirror the general public, but pain compounds symptoms
3. U of M researchers discover compounds to shrink tumors
4. Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue
5. New compounds fight chronic symptoms of bowel disorders
6. New synthetic compounds appear to prevent brain cell death
7. Phenolic compounds may explain Mediterranean diet benefits
8. Vitamin D compounds show promise for prevention of prostate cancer
9. Hebrew University researcher develops compounds to control bacteria
10. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
11. Electric fields have potential as a cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2018)... (PRWEB) , ... December 08, 2018 , ... ... whiskerDocs, the leading provider of telehealth support for pet parents, has become an ... companion animals. , “By supporting the advancement of human-animal bond research, ...
(Date:12/6/2018)... ... December 06, 2018 , ... Pulse8’s Senior ... of Blue Cross and Blue Shield of Kansas City, will present on “Boosting ... 2018 at 2:15pm PT at the Fairmont Grand Del Mar in San Diego, ...
(Date:12/5/2018)... ... , ... Body by Ravi Plastic Surgery and Aesthetics is ... offer the BodyTitePRO treatment. Dr. Ravi Somayazula , practice founder, has dedicated ... techniques to improve the face, breast and body. Together with his partner, Swapna ...
(Date:12/5/2018)... , ... December 05, 2018 , ... ... Initiative leadership training on January 26 at North Monroe Baptist Church, 210 Finks ... 2019 trainings, part of the agency’s effort to educate and equip faith leaders ...
(Date:12/5/2018)... SAN DIEGO (PRWEB) , ... December 05, 2018 , ... ... on the field of nursing. Available starting today and on a weekly rolling basis ... Doctor of Nursing Practice in Executive Leadership (DNP) will prepare degree candidates ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... Calif. (PRWEB) , ... December 05, 2018 , ... Smile ... year in a row moving from the 43rd to 25th position on the ... Choice Awards program, now in its 11th year, relies solely on the input of ...
(Date:12/5/2018)... ... December 05, 2018 , ... WHO: The Institute for ... Livestreaming of four keynote addresses and five spotlight sessions taking place during ... for session descriptions and speakers) , WHEN: Beginning Tuesday, December 11 ( full schedule ...
(Date:12/5/2018)... ... December 04, 2018 , ... The inaugural Steven Schroeder Award ... of Virginia Mason Health System in Seattle, Washington, at The Leapfrog Group ’s ... Costs of Care , a leading non-profit dedicated to curating and disseminating insights ...
Breaking Medicine Technology:
Cached News: